Avaí Bio, Inc. (AVAI)

Avaí Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	47	66	111	55	31	79
Market Cap Growth	-3.42%	-40.41%	102.08%	76.33%	-60.75%	-
Enterprise Value	49	67	111	55	32	80
Last Close Price	0.34	0.48	0.99	1.50	1.18	3.01
PS Ratio	-	-	-	198.16	33.71	65.16
PB Ratio	-16.82	-42.16	-75.45	-86.47	-76.57	-241.61
EV/Sales Ratio	-	-	-	199.94	34.43	65.50
Debt / Equity Ratio	-0.56	-0.58	-0.48	-1.01	-1.48	-1.29
Net Debt / Equity Ratio	-0.54	-0.53	-0.48	-0.84	-1.40	-1.11
Net Debt / EBITDA Ratio	-1.52	-0.77	-0.34	-1.63	-6.30	-1.46
Net Debt / FCF Ratio	-1.32	-0.71	-0.53	-9.74	-1.06	-15.74
Asset Turnover	-	-	-	0.79	1.45	1.96
Quick Ratio	0.02	0.05	0	0.12	0.04	0.11
Current Ratio	0.02	0.05	0.07	0.12	0.39	0.54
Return on Assets (ROA)	-370.28%	-261.11%	-472.18%	-62.66%	-12.44%	-30.57%
Return on Capital Employed (ROCE)	36.90%	73.00%	145.10%	55.10%	31.20%	92.30%
Earnings Yield	-2.19%	-1.73%	-1.92%	-0.64%	-0.41%	-0.38%
FCF Yield	-	-1.76%	-1.20%	-0.10%	-1.72%	-0.03%
Buyback Yield / Dilution	-5.72%	-48.09%	-124.74%	-46.31%	-0.13%	-29.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.